![Frontiers | TGx-DDI, a Transcriptomic Biomarker for Genotoxicity Hazard Assessment of Pharmaceuticals and Environmental Chemicals Frontiers | TGx-DDI, a Transcriptomic Biomarker for Genotoxicity Hazard Assessment of Pharmaceuticals and Environmental Chemicals](https://www.frontiersin.org/files/Articles/468242/fdata-02-00036-HTML/image_m/fdata-02-00036-g004.jpg)
Frontiers | TGx-DDI, a Transcriptomic Biomarker for Genotoxicity Hazard Assessment of Pharmaceuticals and Environmental Chemicals
![Frontiers | TGx-DDI, a Transcriptomic Biomarker for Genotoxicity Hazard Assessment of Pharmaceuticals and Environmental Chemicals Frontiers | TGx-DDI, a Transcriptomic Biomarker for Genotoxicity Hazard Assessment of Pharmaceuticals and Environmental Chemicals](https://www.frontiersin.org/files/Articles/468242/fdata-02-00036-HTML/image_m/fdata-02-00036-g001.jpg)
Frontiers | TGx-DDI, a Transcriptomic Biomarker for Genotoxicity Hazard Assessment of Pharmaceuticals and Environmental Chemicals
![Pharmaceutics | Free Full-Text | Use of In Vivo Imaging and Physiologically-Based Kinetic Modelling to Predict Hepatic Transporter Mediated Drug–Drug Interactions in Rats Pharmaceutics | Free Full-Text | Use of In Vivo Imaging and Physiologically-Based Kinetic Modelling to Predict Hepatic Transporter Mediated Drug–Drug Interactions in Rats](https://pub.mdpi-res.com/pharmaceutics/pharmaceutics-15-00896/article_deploy/html/images/pharmaceutics-15-00896-g001-550.jpg?1678429616)
Pharmaceutics | Free Full-Text | Use of In Vivo Imaging and Physiologically-Based Kinetic Modelling to Predict Hepatic Transporter Mediated Drug–Drug Interactions in Rats
![Molecules | Free Full-Text | Research Methods and New Advances in Drug–Drug Interactions Mediated by Renal Transporters Molecules | Free Full-Text | Research Methods and New Advances in Drug–Drug Interactions Mediated by Renal Transporters](https://www.mdpi.com/molecules/molecules-28-05252/article_deploy/html/images/molecules-28-05252-g002.png)
Molecules | Free Full-Text | Research Methods and New Advances in Drug–Drug Interactions Mediated by Renal Transporters
![Understanding Statin‐Roxadustat Drug–Drug‐Disease Interaction Using Physiologically‐Based Pharmacokinetic Modeling - Dong - 2023 - Clinical Pharmacology & Therapeutics - Wiley Online Library Understanding Statin‐Roxadustat Drug–Drug‐Disease Interaction Using Physiologically‐Based Pharmacokinetic Modeling - Dong - 2023 - Clinical Pharmacology & Therapeutics - Wiley Online Library](https://ascpt.onlinelibrary.wiley.com/cms/asset/33b6288e-5b76-499a-b691-8f6f5bed4c87/cpt2980-fig-0001-m.jpg)
Understanding Statin‐Roxadustat Drug–Drug‐Disease Interaction Using Physiologically‐Based Pharmacokinetic Modeling - Dong - 2023 - Clinical Pharmacology & Therapeutics - Wiley Online Library
![Addressing Today's Absorption, Distribution, Metabolism, and Excretion (ADME) Challenges in the Translation of In Vitro ADME Characteristics to Humans: A Case Study of the SMN2 mRNA Splicing Modifier Risdiplam | Drug Metabolism Addressing Today's Absorption, Distribution, Metabolism, and Excretion (ADME) Challenges in the Translation of In Vitro ADME Characteristics to Humans: A Case Study of the SMN2 mRNA Splicing Modifier Risdiplam | Drug Metabolism](https://dmd.aspetjournals.org/content/dmd/50/1/65/F2.large.jpg)
Addressing Today's Absorption, Distribution, Metabolism, and Excretion (ADME) Challenges in the Translation of In Vitro ADME Characteristics to Humans: A Case Study of the SMN2 mRNA Splicing Modifier Risdiplam | Drug Metabolism
![Preclinical experimental models of drug metabolism and disposition in drug discovery and development - ScienceDirect Preclinical experimental models of drug metabolism and disposition in drug discovery and development - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211383512001438-fx1.jpg)
Preclinical experimental models of drug metabolism and disposition in drug discovery and development - ScienceDirect
![Physiologically based pharmacokinetic modelling and in vivo [I]/K(i) accurately predict P-glycoprotein-mediated drug-drug interactions with dabigatran etexilate. - Abstract - Europe PMC Physiologically based pharmacokinetic modelling and in vivo [I]/K(i) accurately predict P-glycoprotein-mediated drug-drug interactions with dabigatran etexilate. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3925042/bin/bph0171-1043-f1.jpg)
Physiologically based pharmacokinetic modelling and in vivo [I]/K(i) accurately predict P-glycoprotein-mediated drug-drug interactions with dabigatran etexilate. - Abstract - Europe PMC
![Effect of Myricetin on CYP2C8 Inhibition to Assess the Likelihood of Drug Interaction Using In Silico, In Vitro, and In Vivo Approaches | ACS Omega Effect of Myricetin on CYP2C8 Inhibition to Assess the Likelihood of Drug Interaction Using In Silico, In Vitro, and In Vivo Approaches | ACS Omega](https://pubs.acs.org/cms/10.1021/acsomega.2c00726/asset/images/large/ao2c00726_0008.jpeg)
Effect of Myricetin on CYP2C8 Inhibition to Assess the Likelihood of Drug Interaction Using In Silico, In Vitro, and In Vivo Approaches | ACS Omega
![Proposed preliminary conceptual framework for in vivo drug interaction... | Download Scientific Diagram Proposed preliminary conceptual framework for in vivo drug interaction... | Download Scientific Diagram](https://www.researchgate.net/publication/261735991/figure/fig1/AS:271578436993040@1441760753331/Proposed-preliminary-conceptual-framework-for-in-vivo-drug-interaction-evaluation-with.png)